A. Floch

High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.

L. Tahraoui, A. Floch, S. Mondot et al. · Molecular Pharmacology · 1988 · 30 citations

RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.

A. Floch, Anne Bousseau, Emmanuelle Hetier et al. · PubMed · 1992 · 24 citations

Tnf Release, Immunology, Cell Death +18

In vivo pharmacological properties of RPR100893, a novel non-peptide antagonist of the human NK1 receptor

Saliha Moussaoui, François Montier, A. Carruette et al. · Neuropeptides · 1994 · 18 citations

Molecular Pharmacology, Vivo Pharmacological Properties, G Protein-coupled Receptor +9

Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.

L. Tahraoui, A. Floch, Icilio Cavero · Journal of Pharmacology and Experimental Therapeutics · 1990 · 14 citations · Full text

The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.

A. Floch, L. Tahraoui, P. Sédivy et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 12 citations